Magnetic Resonance Imaging |
|
|
|
MRI Magnetic Resonance Imaging | So advanced it's simple Our Magnetic Resonance portfolio of products and services addresses the imaging needs of today by simplifying your workflow, accelerating your imaging processes and helping to build your business. We demonstrate our committment to simplicity by building MRI systems that are advanced, yet easy to use, and designed with the patient in mind. | | Achieva 3.0T TX MRI with MultiTransmit Make a leap forward in 3.0T MRI performance The Achieva 3.0T TX with MultiTransmit parallel RF transmission technology is designed to overcome fundamental challenges of high-field imaging, such as the dielectric effect. Unique to the Achieva 3.0T TX, MultiTransmit reduces dielectric shading to provide optimum image uniformity, consistency and faster scanning. Thus driving the growth of 3T MRI into expanding application areas like breast, body and cardiac imaging. Patient-adaptive RF management provides superb image uniformity and consistency By using multiple RF sources, MultiTransmit can adapt the RF signals to each individual patient by a process known as RF shimming to enhance image uniformity and consistency. This is particularly important for breast and body imaging. Reduced local SAR allows faster scanning What’s more, by using multiple RF sources, MultiTransmit can reduce local Specific Absorption Rate (SAR) and take advantage of optimized RF management to provide ultra-fast scanning with up to 40% increase in scanning speed. All the benefits of 3T imaging, plus: - Enhanced image uniformity and consistency over a broad range of applications
- Higher throughput thanks to faster scans and fewer retakes
- More confidence in diagnostic results
- Broader patient population leading to more referrals
The future of 3T MRI today In 2000, we were the first to introduce SENSE parallel receive imaging, an innovative step that has since been adopted by all major vendors. Now MultiTransmit parallel RF transmission imaging promises to propel high-field MRI to a new level of clinical functionality. | | |
|